Skip to main content
Robert Schott, MD, Cardiology, Emeryville, CA

RobertJSchottMDMPH

Cardiology Emeryville, CA

Chief Medical Officer/Rivus Pharmaceuticals

Dr. Schott is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Schott's full profile

Already have an account?

  • Office

    Nutcracker Therapeutics
    5858 Horton Street, Suite 540
    Emeryville, CA 94608
    Phone+1 916-956-1850

Summary

  • I'm currently the Chief Medical Officer at Nutcracker Therapeutics focused on bringing novel mRNA therapies to the clinic.

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Cardiovascular Disease, 1990 - 1994
  • The University of Michigan School of Public Health
    The University of Michigan School of Public HealthMPH, Epidemiology, 1988
  • University of Michigan
    University of MichiganResidency, Internal Medicine, 1981 - 1984
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 1981
  • The University of Michigan
    The University of MichiganBS, Biomedicine, 1980

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1994 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Clinical LipidologyDiplomate

Awards, Honors, & Recognition

  • Teacher of the Year Deborah Heart and Lung Center, 2010
  • Outstanding Role Model of the Year (Fellows Class of 2010) Deborah Heart and Lung Center, 2010
  • Burgher Fellowship Award American Heart Association, 1991
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Generation and Localization of Monoclonal Antibodies against Fibroblast Growth Factors in Ischaemic, Collateralized Porcine Myocardium  
    Bernotat-Danielowski S, Sharma HS, Schott RJ, Schaper W, Cardiovasc Res, 1/1/1993
  • Gene Injection into the Canine Myocardium as a Useful Model for Studying Gene Expression in the Heart of Large Mammals  
    von Harsdorf R, Schott RJ, Shen Y-T, Vatner SF, Mahdavi V, Nadal-Ginard B, Circ Res, 1/1/1993
  • Growth Factors and Angiogenesis  
    Schott RJ, Morrow LA, Cardiovasc Res, 1/1/1993
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Rapid Glycometabolic Improvement in Type 2 Diabetic (T2D) Patients with an ADA Isocaloric Diet over a 22 Day Confinement in a Phase I Research Unit
    Schott RJ, Gomez K, Stern R, McCleary J, Krentz A, Morrow L, Hompesch M, National Lipid Association, 1/1/2012
  • Anemia subsequent to Repeated Phlebotomy in Type 2 Diabetics (T2D) participating in a Phase I Trial
    Schott RJ, Angeles JE, Larrabee H, Humphreys C, Schott KM, Morrow LA, Hompesch M, American Society for Clinical Pharmacology and Therapeutics, 1/1/2012
  • Effect of Discontinuing Oral Adnti-Diabetic Drugs (OAD) Prior to Enrollment in a Phase I Trial
    Schott RJ, Angeles JE, Larrabee H, Humphreys C, Schott KM, Morrow LA, Hompesch M, American Society for Clinical Pharmacology and Therapeutics, 1/1/2012
  • Join now to see all

Professional Memberships